{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:27:40Z","timestamp":1787027260815,"version":"build-2736575974"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T00:00:00Z","timestamp":1643932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>Clinicians and researchers consider that there are a variety of symptoms that constitute negative symptoms in schizophrenia, and they may use different definitions for the same symptoms. These differences are also reflected in a variety of negative symptom rating scales. Both research and clinical work are negatively affected by the lack of consensus regarding the symptoms that constitute negative symptoms in schizophrenia. Leading research groups have investigated ways to reduce heterogeneity in the domain of negative symptoms in schizophrenia; however, little attention has been paid to regional differences in the concepts of negative symptoms in schizophrenia. The objective of this review was to collect and summarize information about the assessment and treatment of negative symptoms of schizophrenia in Central and Eastern Europe (CEE). Nineteen experts from 17 countries in CEE participated in this project. The participants collected information about their countries, including the following: (1) the most important publications about negative symptoms in schizophrenia (irrespective of the time of their publication); (2) the most frequently used negative symptom of schizophrenia in clinical practice; (3) definitions of frequently used negative symptoms; and (4) treatment of negative symptoms in schizophrenia. The participating experts\/countries most frequently reported the following five negative symptoms: avolition, blunted affect, alogia, asociality, and anhedonia. Several experts also considered other symptoms as belonging to the negative symptom domain, such as a decrease in energy level and changes in personality. The importance of evaluating the long-term course and the relationship between negative symptoms and other symptom domains was also noted. No noticeable differences were reported in the treatment of negative symptoms compared to currently published guidelines and algorithms. The most frequently reported negative symptoms included those defined by the NIMH-MATRICS consensus statement on negative symptoms and recently endorsed in a guidance paper of the European Psychiatric Association. The main differences in the concepts, names, and definitions of primary negative symptoms, especially those related to personality changes, and to the evaluation of the long-term course and relationship between different symptom domains in CEE compared to the current English language literature deserve the attention of psychiatrists and other professionals in this field.<\/jats:p>","DOI":"10.3389\/fpsyt.2021.820801","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T03:07:40Z","timestamp":1643944060000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Assessment and Treatment of Negative Symptoms in Schizophrenia\u2014A Regional Perspective"],"prefix":"10.3389","volume":"12","author":[{"given":"Istvan","family":"Bitter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Raspopova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Szulc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Samochowiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana Valentina","family":"Micluia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Skugarevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00f3bert","family":"Herold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma","family":"Mihaljevic-Peles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nino","family":"Okribelashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozef","family":"Draga\u0161ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginija","family":"Adomaitiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmars","family":"Rancans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Chihai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Maruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadja P.","family":"Mari\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vihra","family":"Milanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rok","family":"Tav\u010dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Mosolov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,4]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/med\/9780198840121.003.0001","article-title":"Definitions and measurement of negative symptoms in schizophrenia","volume-title":"Managing Negative Symptoms of Schizophrenia","author":"Bitter","year":"2020"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1192\/j.eurpsy.2021.11","article-title":"EPA guidance on assessment of negative symptoms in schizophrenia","volume":"64","author":"Galderisi","year":"2021","journal-title":"Eur Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1192\/j.eurpsy.2021.13","article-title":"EPA guidance on treatment of negative symptoms in schizophrenia","volume":"64","author":"Galderisi","year":"2021","journal-title":"Eur Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/schbul\/sbj053","article-title":"The NIMH-MATRICS consensus statement on negative symptoms","volume":"32","author":"Kirkpatrick","year":"2006","journal-title":"Schizophr Bull"},{"key":"B5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jpsychires.2020.08.025","article-title":"Incidence, prevalence and prescription patterns of antipsychotic medications use in Asia and US: a cross-nation comparison with common data model","volume":"131","author":"Su","year":"2020","journal-title":"J Psychiatr Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.euroneuro.2007.08.001","article-title":"Antipsychotic prescription patterns in outpatient settings: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study","volume":"18","author":"Bitter","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jad.2018.11.038","article-title":"Definition of treatment-resistant depression - Asia Pacific perspectives","volume":"245","author":"Ng","year":"2019","journal-title":"J Affect Disord."},{"key":"B8","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/S2215-0366(17)30135-9","article-title":"A blind spot on the global mental health map: a scoping review of 25 years' development of mental health care for people with severe mental illnesses in central and eastern Europe","volume":"4","author":"Winkler","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2174\/1745017901511010158","article-title":"Epidemiology and treatment guidelines of negative symptoms in schizophrenia in Central and Eastern Europe: a literature review","volume":"11","author":"Szkultecka-Debek","year":"2015","journal-title":"Clin Pract Epidemiol Ment Health"},{"key":"B10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1600-0447.2006.00804.x","article-title":"Psychiatry in selected countries of Central and Eastern Europe: an overview of the current situation","volume":"114","author":"Furedi","year":"2006","journal-title":"Acta Psychiatr Scand"},{"key":"B11","first-page":"104","article-title":"Schizophrenia causes significant burden to patients' and caregivers' lives","volume":"28","author":"Szkultecka-Debek","year":"2016","journal-title":"Psychiatr Danub."},{"key":"B12","first-page":"130","article-title":"History of psychiatry in georgia: hidden pages (dedicated to our teachers)","volume":"265","author":"Kentchadze","year":"2017","journal-title":"Georgian Med News"},{"key":"B13","first-page":"409","article-title":"Defektsyndrome und basisstadien endogener psychosen","volume":"34","author":"Huber","year":"1966","journal-title":"Fortsch Neurol Psychiatr."},{"key":"B14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000284602","article-title":"Basic symptoms in schizophrenic and affective psychoses","volume":"22","author":"Ebel","year":"1989","journal-title":"Psychopathology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"766692","DOI":"10.3389\/fpsyt.2021.766692","article-title":"Primary and secondary negative symptoms in schizophrenia","volume":"12","author":"Mosolov","year":"2021","journal-title":"Front Psychiatry."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.21265\/PSYPH.2020.15.30.001","article-title":"Concept, classification and clinical differentiation of negative symptoms inschizophrenia","volume":"1","author":"Mosolov","year":"2020","journal-title":"Sovrem Psih Rasstrojstv."},{"key":"B17","volume-title":"Negative Disorders in the Clinical Picture of Schizophrenia. Study Guide","author":"Raspopova","year":"2021"},{"key":"B18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/med\/9780198840121.003.0003","article-title":"Long-term course of negative symptoms in schizophrenia","volume-title":"Managing Negative Symptoms of Schizophrenia","author":"Smulevich","year":"2020"},{"key":"B19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.15386\/cjmed-864","article-title":"Are negative symptoms in schizophrenia a distinct therapeutic target?","volume":"91","author":"Capatina","year":"2018","journal-title":"Clujul Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.26226\/morressier.5a7070e5d462b80290b571f4","article-title":"Course of negative symptoms sudomanins in schizophrenia: a one year follow-up study","author":"Capa\u0163ina","year":"2018","journal-title":"26th European Congress of Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.21265\/PSYPH.2019.24.24.001","article-title":"Diagnosis of schizophrenia in Russia: the results of a web-based survey of psychiatrists","volume":"1","author":"Neznanov","year":"2019","journal-title":"Sovrem Psih Rasstrojstv"},{"key":"B22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3892\/etm.2021.9707","article-title":"Current perspectives in treating negative symptoms of schizophrenia: a narrative review (Review)","volume":"21","author":"Capatina","year":"2021","journal-title":"Exp Ther Med"},{"key":"B23","first-page":"40","article-title":"Antipsychotics in treatment of predominant negative symptoms in schizophrenia: an update of guidelines","volume":"24","author":"Masopust","year":"2020","journal-title":"Psychiatrie."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.21265\/PSYPH.2020.26.17.001","article-title":"An algorithm for the treatment of primary negative symptoms in schizophrenia","volume":"2","author":"Mosolov","year":"2020","journal-title":"Sovrem Psih Rasstrojstv."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.2147\/NDT.S201726","article-title":"Pharmacological treatment of negative symptoms in schizophrenia: update and proposal of a clinical algorithm","volume":"15","author":"Cerveri","year":"2019","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/med\/9780198840121.003.0005","article-title":"Pharmacologic treatment of negative symptoms: focus on efficacy","volume-title":"Managing Negative Symptoms of Schizophrenia","author":"Czobor","year":"2020"},{"key":"B27","first-page":"209","article-title":"The double-blind sham-controlled study of high-frequency rTMS (20 Hz) for negative symptoms in schizophrenia: negative results","volume":"27","author":"Novak","year":"2006","journal-title":"Neuro Endocrinol Lett"},{"key":"B28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.schres.2007.06.019","article-title":"Treatment of negative symptoms of schizophrenia using repetitive transcranial magnetic stimulation in a double-blind, randomized controlled study","volume":"95","author":"Prikryl","year":"2007","journal-title":"Schizophr Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.schres.2013.06.015","article-title":"A detailed analysis of the effect of repetitive transcranial magnetic stimulation on negative symptoms of schizophrenia: a double-blind trial","volume":"149","author":"Prikryl","year":"2013","journal-title":"Schizophr Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.brs.2015.01.078","article-title":"Repetitive transcranial magnetic stimulation (rTMS) effects on depression, negative symptoms and cognition in schizophrenia","author":"Maslenikov","year":"2015","journal-title":"Brain Stimul."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1007\/s00115-017-0323-1","volume":"88","author":"Fuchs","year":"2017","journal-title":"Nervenarzt."},{"key":"B32","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/schbul\/sbz141","article-title":"Network analysis indicates that avolition is the most central domain for the successful treatment of negative symptoms: evidence from the roluperidone randomized clinical trial","volume":"46","author":"Strauss","year":"2020","journal-title":"Schizophr Bull"},{"key":"B33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.schres.2007.03.008","article-title":"Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure","volume":"93","author":"Gard","year":"2007","journal-title":"Schizophr Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1007\/s00115-003-1474-9","volume":"74","author":"Erkwoh","year":"2003","journal-title":"Nervenarzt."},{"key":"B35","unstructured":"International Statistical Classification of Diseases and Related Health Problems. 11th ed2019"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1093\/schbul\/sbab069","article-title":"Primary negative symptoms: refining the research target","volume":"47","author":"Kirkpatrick","year":"2021","journal-title":"Schizophr Bull"},{"key":"B37","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00406-018-0869-3","article-title":"Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis","volume":"268","author":"Krause","year":"2018","journal-title":"Eur Arch Psychiatry Clin Neurosci"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.820801\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T03:07:53Z","timestamp":1643944073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.820801\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,4]]},"references-count":37,"alternative-id":["10.3389\/fpsyt.2021.820801"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2021.820801","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,4]]},"article-number":"820801"}}